Investor's Business Daily47d agobearish
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Bloomberg48d agobearishVIDEO
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock MoversGuruFocus.com58d agobearish
Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly CompetitionGuruFocus.com58d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffBarrons.com73d agobearish
Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren’t the ReasonThe Wall Street Journal73d agobearish
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth ConcernsInvesting.com95d agobearish
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlookInvestor's Business Daily96d agobearish
Novo Nordisk Dives 6% After Unexpectedly Releasing Earnings A Day EarlyInvestor's Business Daily100d agobearish
Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key LevelsThe Wall Street Journal100d agobearish
Novo Nordisk Stock Drops After Drug Fails in Cardiovascular TrialThe Wall Street Journal100d agobearish
Novo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular TrialSimply Wall St.108d agobearish
How Novo Nordisk’s GLP-1 Advertising Lawsuit Against Eli Lilly (LLY) Has Changed Its Investment Story